Skip to content

Analysis of Endoscopist's Visual Gaze Pattern during Artificial Intelligence Assisted Colorectal Polyp Detection

Analysis of Endoscopist's Visual Gaze Pattern during Artificial Intelligence Assisted Colorectal Polyp Detection - Analysis of endoscopist's VGP during AI-assisted colorectal polyp detection

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000052891
Enrollment
60
Registered
2023-11-25
Start date
2023-11-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal polyp

Interventions

During colonoscopy, CADe (CAD-EYE, Fujifilm Corporation) and the VGP real-time analysis system we developed are operated simultaneously to record and store inspection movies with the endoscopist&#39
s VGP displayed on the endoscopic image.

Sponsors

International University of Health and Welfare
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients who are undergoing colonoscopy. 2. Patients whose age is between 20 and 90 years old. 3. Patients with a performance status (ECOG) of 0 (no limitation in daily activities), 1 (able to perform light tasks but not physical labor), or 2 (able to walk and perform personal activities but not light tasks) 4. Patient's participation in the study has been fully explained to him/her and his/her written consent has been obtained.

Exclusion criteria

Exclusion criteria: 1. Patients with a history of inflammatory bowel disease (ulcerative colitis, Crohn's disease, Behcet's disease). 2. Patients with hereditary or non-hereditary gastrointestinal polyposis. 3) Patients with hereditary non-polyposis colorectal cancer (Lynch syndrome). 3. Patients with hereditary non-polyposis colorectal cancer (Lynch syndrome). 4. Patients with known severe diverticular disease of the colon that makes colonoscopy difficult and dangerous. 5. Patients who are unable to take colonoscopy pretreatment medication (laxatives). 6. Patients who are allergic to colonoscopy pretreatment drugs or sedatives. 7. Pregnant women. 8. Those who are breast-feeding. 9. Those who have not obtained consent to participate in the study 10. Those who are deemed inappropriate by the study investigator.

Design outcomes

Primary

MeasureTime frame
Percentage of lesions that CADe was able to automatically detect that were actually recognized by the endoscopist

Secondary

MeasureTime frame
1. Time taken for the endoscopist to recognize lesions that were automatically detected by CADe 2. Analysis of features of lesions automatically detected by CADe but not recognized by the endoscopist 3. Analysis of lesion features that the endoscopist could recognize but CADe could not automatically detect 4. Percentage of endoscopists gazing at sites where CADe falsely detected bubbles or remaining stools (percentage of endoscopists gazing at CADe falsely detected sites) 5. Analysis of patients background in relation to the percentage that CADe falsely detected sites 6. Analysis of VGP of endoscopists during lesion detection by CADe

Countries

Japan

Contacts

Public ContactFumiaki Ishibashi

International University of Health and Welfare Ichikawa Hospital Department of Gastroenterology

ishibashi-gast@iuhw.ac.jp047-375-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026